Charles E. Binkley, MD, Michael S. Politz, MA, and Brian P. Green, PhD
If the safe-and-effective standard for judging devices’ potential as therapy or enhancement is inadequate, one might wonder whether BCI regulation should be overseen by the FDA.
AMA J Ethics. 2021;23(9):E745-749. doi:
10.1001/amajethics.2021.745.
Dr Charles Binkley joins Ethics Talk to discuss his article, coauthored with Michael Politz and Dr Brian Green: "Who, If Not the FDA, Should Regulate Implantable Brain-Computer Interface Devices?"
Dr Jeremy Weleff joins Ethics Talk to discuss his article, coauthored with Dr Dawn Potter: “Key Updates to Understanding Roles of Childhood Trauma in Overall Health.”
AMA Journal of Ethics theme editor Terri Davis, a third-year MD student at West Virginia University School of Medicine, interviewed Ranit Mishori, MD, about how to respond to incidents of suspected human trafficking in health care settings.
Public health surveillance for infectious disease provides a model for a mandatory reporting policy for human trafficking, which poses risks for survivors.
AMA J Ethics. 2017;19(1):45-53. doi:
10.1001/journalofethics.2017.19.1.stas1-1701.